| | 654671-78-0 Basic information More.. |
| Product Name: | Sitagliptin phosphate | | Synonyms: | 7-[(3R)-3-Amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-α]pyrazine-phosphate;Sitagliptin phosphate;4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine phosphate;sitagpliptin;Sitagliptin phosphate 4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine phosphate;Sitagliptin phosphate/Sitagliptin phosphate Monohydrate/Sitagliptin;Sitagliptin phosphate (Cas:654671-78-0...;(3R)-3-Amino-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-1-butanone phosphate | | CAS: | 654671-78-0 | | MF: | C16H15F6N5O.H3PO4 | | MW: | 505.31 | | EINECS: | 1806241-263-5 | | Mol File: | 654671-78-0.mol |  |
Use
Sitagliptin phosphate (trade name januvia) is the dpp-4 inhibitor first clinically approved for the treatment of type 2 diabetes, developed by germany company merck, and was listed in 2006 in mexico and the united states in 2007, also obtained eu approval for the treatment of type 2 diabetes. china approval was soon, currently sitagliptin phosphate tablets has become the second largest drug of oral diabetes drugs in us.
- Sitagliptin Phosphate
-
- US $0.00 / Kg/Bag
- 2024-11-27
- CAS:654671-78-0
- Min. Order: 2Kg/Bag
- Purity: 99% up, High Density
- Supply Ability: 20 tons
- Sitagliptin phosphate
-
- US $33.00-57.00 / mg
- 2024-11-19
- CAS:654671-78-0
- Min. Order:
- Purity: 99.72%
- Supply Ability: 10g
- Sitagliptin Phosphate
-
- US $0.00 / g
- 2024-11-18
- CAS:654671-78-0
- Min. Order: 1g
- Purity: More Than 99%
- Supply Ability: 50kg/Month
|
|
654671-78-0
Recommend Suppliers |
|